TY - JOUR
T1 - IMI - Clinical Management Guidelines Report
AU - Gifford, KL
AU - Richdale, K
AU - Kang, P
AU - Aller, TA
AU - Lam, CS
AU - Liu, YM
AU - Mulder, J
AU - Michaud, L
AU - Orr, JB
AU - Rose, KA
AU - Saunders, KJ
AU - Seidel, Dirk
AU - Tideman, JWL
AU - Sankaridurg, P
N1 - Acceptance from webpage
OA article (CC-BY-NC-ND) but doesn't meet GCU OA definition.
Available in Aston repository but not deposited within 3m of acceptance.
Exception email to author? ET 15/11/19
PY - 2019/2/28
Y1 - 2019/2/28
N2 - Best practice clinical guidelines for myopia control involve an understanding of the epidemiology of myopia, risk factors, visual environment interventions, and optical and pharmacologic treatments, as well as skills to translate the risks and benefits of a given myopia control treatment into lay language for both the patient and their parent or caregiver. This report details evidence-based best practice management of the pre-, stable, and the progressing myope, including risk factor identification, examination, selection of treatment strategies, and guidelines for ongoing management. Practitioner considerations such as informed consent, prescribing off-label treatment, and guides for patient and parent communication are detailed. The future research directions of myopia interventions and treatments are discussed, along with the provision of clinical references, resources, and recommendations for continuing professional education in this growing area of clinical practice.
AB - Best practice clinical guidelines for myopia control involve an understanding of the epidemiology of myopia, risk factors, visual environment interventions, and optical and pharmacologic treatments, as well as skills to translate the risks and benefits of a given myopia control treatment into lay language for both the patient and their parent or caregiver. This report details evidence-based best practice management of the pre-, stable, and the progressing myope, including risk factor identification, examination, selection of treatment strategies, and guidelines for ongoing management. Practitioner considerations such as informed consent, prescribing off-label treatment, and guides for patient and parent communication are detailed. The future research directions of myopia interventions and treatments are discussed, along with the provision of clinical references, resources, and recommendations for continuing professional education in this growing area of clinical practice.
KW - Clinical considerations
KW - Myopia control
KW - Myopia progression
KW - Patient communication
KW - Practitioner education
U2 - 10.1167/iovs.18-25977
DO - 10.1167/iovs.18-25977
M3 - Article
SN - 0146-0404
VL - 60
SP - M184-M203
JO - Investigative Ophthalmology & Visual Science
JF - Investigative Ophthalmology & Visual Science
IS - 3
ER -